Concepedia

Charles Baker‐Glenn

CB

Statistics

Publications

12

Citations

565

H-Index

11

Active since

2004

Affiliations

University of Nottingham(Current)

GlaxoSmithKline (United Kingdom)

University of Oxford

Health and Functional Exposomics

Charles Baker‐Glenn is an author at University of Nottingham specializing in chemistry, pharmacy, and medicinal chemistry.

Publications per year

2004–2021

12

Publications

12

Discovery of Highly Potent, Selective, and Brain-Penetrable Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors

Anthony A. Estrada, Xingrong Liu, Charles Baker‐Glenn et al. · Journal of Medicinal Chemistry · 2012 · 164 citations · Full text

, , +17

Discovery of Highly Potent, Selective, and Brain-Penetrant Aminopyrazole Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors

Anthony A. Estrada, Bryan Chan, Charles Baker‐Glenn et al. · Journal of Medicinal Chemistry · 2013 · 126 citations · Full text

, , +17

Total Synthesis of (−)‐Ulapualide A: The Danger of Overdependence on NMR Spectroscopy in Assignment of Stereochemistry

Gerald Pattenden, Neil J. Ashweek, Charles Baker‐Glenn et al. · Angewandte Chemie International Edition · 2007 · 52 citations

, , +10

Discovery of a Highly Selective, Brain-Penetrant Aminopyrazole LRRK2 Inhibitor

Bryan Chan, Anthony A. Estrada, Huifen Chen et al. · ACS Medicinal Chemistry Letters · 2012 · 44 citations · Full text

, , +15

A Catalytic Asymmetric Bioorganic Route to Enantioenriched Tetrahydro- and Dihydropyranones

Charles Baker‐Glenn, Neil S. Hodnett, Maud Reiter et al. · Journal of the American Chemical Society · 2005 · 41 citations

, , +13

1–5 of 12